# A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Abiraterone Following Administration of Abiraterone Acetate Tablets in Healthy Adult Men

> **NCT01588782** · PHASE1 · COMPLETED · sponsor: **Janssen Research & Development, LLC** · enrollment: 20 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** Period 1: Abiraterone
- **DRUG:** Period 2: Abiraterone/Ketoconazole
- **DRUG:** Period 2: Abiraterone/Ketoconazole

## Key facts

- **NCT ID:** NCT01588782
- **Lead sponsor:** Janssen Research & Development, LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2012-01
- **Primary completion:** 2012-02
- **Final completion:** 2012-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2012-11-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01588782

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01588782, "A Study to Assess the Effect of Ketoconazole on the Pharmacokinetics of Abiraterone Following Administration of Abiraterone Acetate Tablets in Healthy Adult Men". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT01588782. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*